Cargando…

SARS-CoV-2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity

[Image: see text] The Delta variant spreads more rapidly than previous variants of SARS-CoV-2. This variant comprises several mutations on the receptor-binding domain (RBD(Delta)) of its spike glycoprotein, which binds to the peptidase domain (PD) of angiotensin-converting enzyme 2 (ACE2) receptors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Golcuk, Mert, Hacisuleyman, Aysima, Yilmaz, Sema Zeynep, Taka, Elhan, Yildiz, Ahmet, Gur, Mert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113008/ https://www.ncbi.nlm.nih.gov/pubmed/35533364 http://dx.doi.org/10.1021/acs.jcim.1c01523

Ejemplares similares

Omicron BA.1 and BA.2 variants increase the interactions of SARS-CoV-2 spike glycoprotein with ACE2
por: Golcuk, Mert, et al.
Publicado: (2022)

Entropy Transfer between Residue Pairs and Allostery in Proteins: Quantifying Allosteric Communication in Ubiquitin
por: Hacisuleyman, Aysima, et al.
Publicado: (2017)

Structural and functional insight into the regulation of kinesin-1 by microtubule associated protein MAP7
por: Ferro, Luke S, et al.
Publicado: (2022)

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
por: Huo, Jiangdong, et al.
Publicado: (2020)

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
por: Huo, Jiandong, et al.
Publicado: (2021)

Dynein’s directionality is controlled by the angle and length of its stalk
por: Can, Sinan, et al.
Publicado: (2019)

Investigation of Serum Angiotensin-Converting Enzyme (ACE) Concentration and ACE Gene Polymorphism in Patients With SARS-CoV-2 Pneumonia Admitted to the Emergency Department
por: Goren, Tarik, et al.
Publicado: (2022)

A force-sensitive mutation reveals a spindle assembly checkpoint-independent role for dynein in anaphase progression
por: Salvador-Garcia, David, et al.
Publicado: (2023)

Identification and characterization of blocking nanobodies against human CD70: Identification and characterization of blocking nanobodies
por: Zhang, Xin, et al.
Publicado: (2022)

Antibody–nanobody combination increases their neutralizing activity against SARS-CoV-2 and nanobody H11-H4 is effective against Alpha, Kappa and Delta variants
por: Nguyen, Hung, et al.
Publicado: (2022)

ACE2-Targeting antibody suppresses SARS-CoV-2 Omicron and Delta variants
por: Ou, Jianxia, et al.
Publicado: (2022)

Combining Optimal Control Theory and Molecular Dynamics for Protein Folding
por: Arkun, Yaman, et al.
Publicado: (2012)

Computational Design of New Peptide Inhibitors for Amyloid Beta (Aβ) Aggregation in Alzheimer's Disease: Application of a Novel Methodology
por: Eskici, Gözde, et al.
Publicado: (2013)

An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
por: Hanke, Leo, et al.
Publicado: (2020)

Nanobodies against SARS-CoV-2 reduced virus load in the brain of challenged mice and neutralized Wuhan, Delta and Omicron Variants
por: Pavan, María Florencia, et al.
Publicado: (2023)

CAMEL NANOBODIES NEUTRALIZE SARS-COV-2 VARIANTS
por: Hong, Jessica, et al.
Publicado: (2023)

A Competitive Panning Method Reveals an Anti-SARS-CoV-2 Nanobody Specific for an RBD-ACE2 Binding Site
por: He, Siqi, et al.
Publicado: (2023)

Structural basis for SARS-CoV-2 Delta variant recognition of ACE2 receptor and broadly neutralizing antibodies
por: Wang, Yifan, et al.
Publicado: (2022)

Microseconds Simulations Reveal a New Sodium-binding Site and the Mechanism of Sodium-coupled Substrate Uptake by LeuT
por: Zomot, Elia, et al.
Publicado: (2015)

A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration
por: Wu, Xilin, et al.
Publicado: (2021)

Endotracheal Intubation Without Neuromuscular Blocking Agents: Is It a Good and Safe Option?
por: Akan, Mert, et al.
Publicado: (2012)

The Delta Variant Mutations in the Receptor Binding Domain of SARS-CoV-2 Show Enhanced Electrostatic Interactions with the ACE2
por: Goher, Shaimaa S., et al.
Publicado: (2021)

Deciphering the Impact of Mutations on the Binding Efficacy of SARS-CoV-2 Omicron and Delta Variants With Human ACE2 Receptor
por: Khan, Alamgir, et al.
Publicado: (2022)

Nanobodies against Pfs230 block Plasmodium falciparum transmission
por: Dietrich, Melanie H., et al.
Publicado: (2022)

Pyroptosis inhibiting nanobodies block Gasdermin D pore formation
por: Kopp, Anja, et al.
Publicado: (2023)

Functional permanent 2:1 atrioventricular block treated with cardioneuroablation: Case report
por: Aksu, Tolga, et al.
Publicado: (2015)

Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants
por: Wirnsberger, Gerald, et al.
Publicado: (2021)

Clinical grade ACE2 as a universal agent to block SARS‐CoV‐2 variants
por: Monteil, Vanessa, et al.
Publicado: (2022)

Abstract 2702: Highly synergistic combinations of nanobodies that target SARS-CoV-2 reduce viral load in hACE2 transgenic mice
por: Olivier, Paul, et al.
Publicado: (2023)

Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sites
por: Williams, Thomas L., et al.
Publicado: (2021)

SARS-CoV-2 pan-variant inhibitory peptides deter S1-ACE2 interaction and neutralize delta and omicron pseudoviruses
por: Shah, Masaud, et al.
Publicado: (2022)

SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice
por: Lee, Katherine S., et al.
Publicado: (2022)

Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape
por: Koenig, Paul-Albert, et al.
Publicado: (2021)

Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein
por: Lu, Qizhong, et al.
Publicado: (2021)

ACE2 and Diabetes: ACE of ACEs?
por: Batlle, Daniel, et al.
Publicado: (2010)

Essential oils block cellular entry of SARS-CoV-2 delta variant
por: Torres Neto, Luiz, et al.
Publicado: (2022)

Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo
por: Zottel, Alja, et al.
Publicado: (2023)

Influence of Point Mutations on PR65 Conformational Adaptability: Insights from Nanoaperture Optical Tweezer Experiments and Molecular Simulations
por: Bahar, Ivet, et al.
Publicado: (2023)

Camel nanobodies broadly neutralize SARS-CoV-2 variants
por: Hong, Jessica, et al.
Publicado: (2021)

Structural basis of nanobodies neutralizing SARS-CoV-2 variants
por: Shi, Zhenzhong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1tfbdjbvqbbj2gtj1tgvc2gda6